维普期刊资源整合服务平台（V6.5）

79篇 您的检索式：作者名="HUI EP"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Randomized phase Ⅱ trial of con- current cisplatin- radiotherapy with or without neoadjuvant docetax- el and cisptatin in advanced nasopharyngeal carcinoma显示文摘	Hui EP Ma BB Leung SF	2009	J Clin Oncol2009，27，2：	1
2	Randomized phase Ⅱ trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma显示文摘	Hui EP Ma BB Leung SF	2009	J Clin Oncol2009，27，2：	1
3	Prevention of hepatitis B virus reactivation in patients with nasopharyngeal carcinoma with lamivudine 显示文摘	YEO W HUI EP CHAN AT	2005	Am J Clin Oncol2005，28，4：	1
4	Randomized phase Ⅱ trial of concurrent Cisplatin-radiotherapy with or without neoadjuvant Docetaxel and Cisplatin in advanced nasopharyngeal carcinoma显示文摘	Hui EP Ma BB Leung SF	2009	J Clin Oncol2009，27，2：	1
5	CD4and CD8T cell responses to tumour-associated Epstein-Barr virus antigens in nasopharyngeal carcinoma patients显示文摘	Lin X Gudgeon NH Hui EP	2008	Cancer Immunol Immunother2008，7，7：	1
6	The activity of mTOR inhibitor RAD001 (everolimus)in nasopharyngeal carcinoma and cisplatin-resistant cell lines 显示文摘	SMa BB Lui VW Hui EP	2010	Invest New Drugs2010，28，4：	1
7	Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoad juvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma显示文摘	Hui EP Ma BB Leung SF	2009	J Clin Oncol2009，27，2：	1
8	Antitumor effect and enhance- ment of eytotoxic drug activity by cetuximab in nasopharyngeal carcinomacells 显示文摘	Sung FL Poon TC Hui EP	2005	In Vivo2005，19，1：	1
9	Embolization efficacy and treatment ef- fectiveness of transarteria therapy for unresectable hepatocellular car- cinoma:acase- controlled comparison of transarterial ethanol ablation with lipiodol - ethanol mixture versus transcatheter arterial chemoem bolization 显示文摘	Yu SC I-Iui JW Hui EP	2009	J Vase Interv Radio12009，20，3：	1
10	Antitumor effect and en- hancement of cytotoxic drug activity by cetuximab in na- sopharyngeal carcinoma cells 显示文摘	Sung FL Pooh TC Hui EP	2005	In Vivo2005，19，1：	1
11	Randomized phase II trial of concurrent cisplatin-radiotherapy wit Il or witllout neoadjuvant docetaxel and cisptinin advncedn as opharyngeal carcinoma显示文摘	Hui EP Ma BB Leung SF et a1	2009	J Clin Oncol2009，27，2：	1
12	Randomized phase Ⅱ trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanved nasopharyngeal carcinoma显示文摘	Hui EP Ma BB Leung SF		0，，2：	1
13	CD4 and CD8 T cell responses to tumour-associated Epstein-Barr virus antigens in nasopharyngeal carcinoma patients 显示文摘	Lin X Gudgeon NH Hui EP	2008	Cancer Immunol Immunother2008，57，7：	1
14	The activity of roTOR inhibitor RAD001 (everolimus) in nasopharyngeal carcinoma and cispla- tin-resistant celi Iines 显示文摘	Ma BB Lui VW Hui EP	2010	Invest New Drugs2010，28，：	1
15	Systemic approach to improving treatment outcome in nasopharyngeal carcinoma:current and future directions显示文摘	Ma BB Hui EP Chan AT	2008	Cancer Sci2008，99，7：	1
16	Randomized phase II trial of concurrent cisplatin- radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma 显示文摘	Hui EP Ma BB Leung SF	2009	J Clin Oncol2009，27，2：	1
17	Plasma osteopontin,hypoxia,and response to radiotherapy in nasopharyngeal cancer显示文摘	Hui EP Sung FL Yu BK	2008	Clin Cancer Res2008，14，21：	1
18	Population- based differences in treat- ment outcome following anticancer drug therapies显示文摘	Ma BB Hui EP Mok TS	2010	Lancet Oncol2010，11，1：	1
19	The activity of roTOR inhibitor RAD001 (everolimus) in nasopharyngeal carci- noma and cisplatin-resistant cell lines显示文摘	Ma BB Lui VW Hui EP	2010	Invest New Drugs2010，28，4：	1
20	Prevention of hepatitis B virus reactivation in patients with nasopharyngeal carcinoma with lamivudine 显示文摘	Yeo W Hui EP Chan AT	2005	Am J Clin Oncol2005，28，4：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示